期刊文献+

血清PCT联合痰培养检测在呼吸道感染疾病中的应用 被引量:6

Application of Serum PCT Combined with Sputum Culture to Detection of Respiratory Tract Infection
原文传递
导出
摘要 目的:研究血清降钙素原(PCT)联合痰培养检测在呼吸道感染疾病中的应用价值。方法:选择2012年1月至2014年12月在我院接受治疗的呼吸道感染患者100例进行研究。分析痰培养菌群的分布情况以及PCT的检测结果,对比痰培养细菌感染者及真菌感染者的菌种分类及PCT检测结果。结果:检出病原菌的患者PCT水平均分别显著高于正常菌群及未见细菌生长的患者,差异均有统计学意义(均P<0.05)。细菌感染PCT阳性比例与真菌感染相比,差异无统计学意义(P>0.05)。细菌感染中,革兰氏阳性菌的PCT水平(0.74±0.33μg/L)与革兰氏阴性菌(0.72±0.24μg/L)对比,差异无统计学意义(P>0.05)。真菌感染中,白假丝酵母菌及烟曲霉菌的PCT阳性比例最高,分别为60.00%及80.00%。结论:血清PCT与痰培养检测应用于评价有呼吸道感染的患者病情,具有一定的反馈意义,但无法确定患者的呼吸道感染究竟是细菌感染亦或是真菌感染。 Objective: To study the application value of serum procalcitonin(PCT) combined with sputum culture in the detection of respiratory tract infection. Methods: A total of 100 patients with respiratory tract infection, who were treated in Panjin Center Hospital from January 2012 to December 2014, were chosen as research subjects. The flora distribution of sputum culture and the corresponding PCT levels were analyzed. The bacterial species distribution of bacterial infection and fungal infection of sputum culture and the corresponding PCT levels were compared. Results: The PCT levels of patients with detected pathogenic bacteria were significantly higher than those of patients with normal flora and no bacterial growth, the differences were statistically significant(P〈0.05). PCT positive rate of patients with bacterial infection had no significant difference compared with the patients with fungal infection(P〉0.05). In bacterial infection, there was no statistically significant difference between the ratio of PCT level of the positive gram bacteria(0.74 ±0.33 μg/L)to PCT level of the negative gram bacteria(0.72±0.24 μg/L)(P〉0.05). The PCT positive rates of candida albicans(60%) and aspergillus starter(80%) were the highest in fungal infection. Conclusion: Applicatin of detection of serum PCT plus sputum culture to the evaluation of patients with respiratory tract infection has a certain feedback value, but it can not judge whether it is bacterial infection or fungal infection.
出处 《现代生物医学进展》 CAS 2016年第2期323-325,385,共4页 Progress in Modern Biomedicine
关键词 血清PCT 痰培养 呼吸道感染 疾病应用 Serum PCT Sputum culture Respiratory tract infection Application
  • 相关文献

参考文献20

  • 1Z hu G, Zhu J, Song L, et al. Combined use of biomarkers for distinguishing between bacterial and viral etiologies in pediatric lower respiratory tract'infections[J]. Infect Dis (Lond), 2015, 1(24): 1-5.
  • 2Hoshina T, Nanishi E, Kanno S, et al. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract Infection in hospitalized childran:difference of the diagnostic performance between acute pneumonia and bronchitis [J]. J Infect Chemother, 2014, 20(10): 616-620.
  • 3Dusemtmd F, Bucher B, Meyer S, et al. Influence of procalcitonin on decision to start antibiotic treatment in patients with a lower respiratory tract infection:insight from the observational multicentric ProREAL surveillance [J]. Eur J Clin Mierobiol Infect Dis, 2013, 32 (1): 51-60.
  • 4Baer G, Baumann P, Buettcher M, et al. Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial[J]. PLoS One, 2013, 8(8): 419-420.
  • 5李景攀.重症监护病房患者下呼吸道感染菌群的分布特点及耐药性分析[J].宁夏医科大学学报,2014,36(1):76-78. 被引量:5
  • 6Falsey AR, Becker KL, Swinbume AJ, et al. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation [J]. J Infect Dis, 2013, 208(3): 432-441.
  • 7Mkopi A, Range N, Amuri M, et al. Health workers' performance in the implementation of Patient Centred Tuberculosis Treatment (PCT) strategy under programmatic conditions in Tanzania: a cross sectional study[J]. BMC Health Serv Res, 2013, 16(13): 101-102.
  • 8Chert H, Cheng ZB, Yu RG, et al. Procalcitonin as a predictor of moderate to severe acute respiratory distress syndrome after cardiac surgery with cardiopulmonary bypass:a study protocol for a prospective cohort study[J]. BMJ Open, 2014, 4( 10): 6344-6345.
  • 9杨静,董晨明,李俊艳,张红松,张虹,宋瑞霞,杨朝辉,冯芳,齐艳.急性呼吸窘迫综合征呼吸机捆绑式治疗及其与炎症生物标志物的关系[J].中华危重病急救医学,2014,26(8):544-548. 被引量:17
  • 10Lee NS, Daniels LB. Personalized CI-IF treatment:PCT to guide therapy in heart failure patients[J]. Int J Cardiol, 2014, 176(2): 307-308.

二级参考文献9

共引文献20

同被引文献43

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部